Aksys, Ltd.

Aksys expects to report loss of $0.22 per share

Published in Pharma Investments, Ventures and Law Weekly, April 2nd, 2006

Aksys, Ltd., (AKSY), a developer of dialysis systems, reported preliminary results for the fourth quarter and year ended December 31, 2005 with a net loss for the fourth quarter of $6,735,000, or $0.22 per share, compared to a net loss of $7,881,000, or $0.26 per share, for the fourth quarter of 2004.

"2005 proved to be a learning year for Aksys. We accomplished a number of key objectives, which included establishing market trials with several national dialysis center chains, working out the logistical issues of installing and servicing the PHD units and recruiting patients. We have learned a lot from our accomplishments and look forward to the opportunities and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2006-04-02)

More Articles from Pharma Investments, Ventures and Law Weekly

Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals reports loss of $10.2M
Advaxis, Inc.
Fredrick D. Cobb appointed vice president of finance at Advaxis
Amgen
Amgen donates $1.1M to The Wellness Community
Amicas, Inc.
Amicas reports 17% increase in revenue
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals reports revenues of $2M
Antares Pharma, Inc.
Antares to raise approximately $11M in a private placement
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry